Latest Jpmorgan News

JPMorgan Asset Management has announced the final cash distributions for February 2025 across several of its active ETFs, providing investors with key dates and reinvestment options.

AdAlta has fast-tracked its cellular immunotherapy growth by signing two new term sheets for clinical-stage CAR-T products from Asia, pivoting to focus on in-licensing and clinical trials while winding down internal R&D on its antifibrotic drug AD-214.

JPMorgan Asset Management has updated its February 2025 cash distribution amounts for several of its equity premium income ETFs, reinforcing its commitment to delivering steady income streams to investors.

JPMorgan Asset Management has announced estimated cash distributions for its suite of equity premium income ETFs for February 2025, providing investors with key dates and payout expectations.

JPMorgan Asset Management has announced estimated cash distributions for January 2025 across four key ETFs, signaling steady income opportunities for investors ahead of the new year.

JPMorgan Asset Management has announced estimated cash distributions for January 2025 across four of its key equity premium income ETFs, providing investors with timely guidance on expected income and important dates.

JPMorgan Asset Management has announced estimated cash distributions for January 2025 across its suite of equity premium income ETFs, providing investors with key dates and payout expectations.